These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25220590)

  • 1. Progressive genomic instability in the Nup98-HoxD13 model of MDS correlates with loss of the PIG-A gene product.
    Byrne M; Bennett RL; Cheng X; May WS
    Neoplasia; 2014 Aug; 16(8):627-33. PubMed ID: 25220590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.
    Balderman SR; Li AJ; Hoffman CM; Frisch BJ; Goodman AN; LaMere MW; Georger MA; Evans AG; Liesveld JL; Becker MW; Calvi LM
    Blood; 2016 Feb; 127(5):616-25. PubMed ID: 26637787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men.
    Slape C; Lin YW; Hartung H; Zhang Z; Wolff L; Aplan PD
    J Natl Cancer Inst Monogr; 2008; (39):64-8. PubMed ID: 18648006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model.
    Xu H; Menendez S; Schlegelberger B; Bae N; Aplan PD; Göhring G; Deblasio TR; Nimer SD
    Blood; 2012 Oct; 120(15):3089-97. PubMed ID: 22927245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief report: Loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice.
    Humeniuk R; Koller R; Bies J; Aplan P; Wolff L
    Stem Cells; 2014 May; 32(5):1361-6. PubMed ID: 24449168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.
    Lin YW; Slape C; Zhang Z; Aplan PD
    Blood; 2005 Jul; 106(1):287-95. PubMed ID: 15755899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia.
    Guirguis AA; Slape CI; Failla LM; Saw J; Tremblay CS; Powell DR; Rossello F; Wei A; Strasser A; Curtis DJ
    Cell Death Differ; 2016 Jun; 23(6):1049-59. PubMed ID: 26742432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.
    Gough SM; Chung YJ; Aplan PD
    PLoS One; 2012; 7(5):e36876. PubMed ID: 22606303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome.
    Chung YJ; Robert C; Gough SM; Rassool FV; Aplan PD
    Leuk Res; 2014 Jan; 38(1):95-102. PubMed ID: 23958061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
    Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
    Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells.
    Wang H; Sun J; Zhang B; Zhao D; Tong H; Wu H; Li X; Luo Y; Dong D; Yao Y; McDonald T; Stein AS; Al Malki MM; Pichiorri F; Carlesso N; Kuo YH; Marcucci G; Li L; Jin J
    Clin Transl Med; 2021 Oct; 11(10):e610. PubMed ID: 34709739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome.
    Slape CI; Saw J; Jowett JB; Aplan PD; Strasser A; Jane SM; Curtis DJ
    Blood; 2012 Sep; 120(12):2475-83. PubMed ID: 22855610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
    Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK
    Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl.
    Slape C; Liu LY; Beachy S; Aplan PD
    Blood; 2008 Sep; 112(5):2017-9. PubMed ID: 18566322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.
    Slape C; Hartung H; Lin YW; Bies J; Wolff L; Aplan PD
    Cancer Res; 2007 Jun; 67(11):5148-55. PubMed ID: 17545593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome.
    Chung YJ; Khawaja G; Wolcott KM; Aplan PD
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30346380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice.
    Cheng X; Byrne M; Brown KD; Konopleva MY; Kornblau SM; Bennett RL; May WS
    Blood; 2015 Sep; 126(13):1585-94. PubMed ID: 26202421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome.
    Boehrer S; Adès L; Tajeddine N; Hofmann WK; Kriener S; Bug G; Ottmann OG; Ruthardt M; Galluzzi L; Fouassier C; Tailler M; Olaussen KA; Gardin C; Eclache V; de Botton S; Thepot S; Fenaux P; Kroemer G
    Oncogene; 2009 Jun; 28(22):2205-18. PubMed ID: 19398952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR2/6 signaling promotes the expansion of premalignant hematopoietic stem and progenitor cells in the NUP98-HOXD13 mouse model of MDS.
    Monlish DA; Greenberg ZJ; Bhatt ST; Leonard KM; Romine MP; Dong Q; Bendesky L; Duncavage EJ; Magee JA; Schuettpelz LG
    Exp Hematol; 2020 Aug; 88():42-55. PubMed ID: 32652111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related epigenetic drift in the pathogenesis of MDS and AML.
    Maegawa S; Gough SM; Watanabe-Okochi N; Lu Y; Zhang N; Castoro RJ; Estecio MR; Jelinek J; Liang S; Kitamura T; Aplan PD; Issa JP
    Genome Res; 2014 Apr; 24(4):580-91. PubMed ID: 24414704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.